Primary pulmonary lymphoproliferative neoplasms.

Lung India · 2018 · PMC5946555 · PMID 29697079

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Furthermore, PFS showed a trend in favor of patients treated with immunotherapy and immunochemotherapy versus those receiving chemotherapy alone.[ 9 ] Zucca et al . reported in MALT-PPL, the combination of rituximab plus chemotherapy may be superior to chemotherapy alone with regards to response rate and event-free survival,[ 9 ,

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.